Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients.

被引:0
|
作者
Aoyama, C.
Penner, K.
Ostrzega, N.
Rao, J.
Walsh, C.
Dorigo, O.
Cass, I.
Balzer, B.
Holschneider, C.
机构
[1] Olive View UCLA Med Ctr, Sylmar, CA USA
[2] UCLA Med Ctr, Los Angeles, CA USA
[3] Cedar Sinai Med Ctr, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
997
引用
收藏
页码:236A / 236A
页数:1
相关论文
共 50 条
  • [31] Fertility-preserving treatment in young patients with endometrial carcinoma and atypical hyperplasia
    Fujiwara, H.
    Takei, Y.
    Taneichi, A.
    Saga, Y.
    Imai, M.
    Jobo, T.
    Suzuki, M.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S75 - S75
  • [32] Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study
    Barr, Chloe E.
    Sergeant, Jamie C.
    Agnew, Heather J.
    Bolton, James
    McVey, Rhona J.
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (08) : 941 - 948
  • [33] Expression of progesterone receptor and p4EBP1 as molecular predictors of response to progestin treatment in endometrial adenocarcinoma and complex atypical hyperplasia
    Penner, Kristine
    Wadehra, Madhuri
    Steinhardt, Angela
    Hogue, Claire
    Cass, Ilana
    Walsh, Christine
    Holschneider, Christine
    Braun, Jonathan
    Dorigo, Oliver
    CANCER RESEARCH, 2011, 71
  • [34] Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
    Jing, Chu-Yu
    Li, Sheng-Nan
    Shan, Bo-Er
    Zhang, Wei
    Tian, Wen-Juan
    Ren, Yu-Lan
    Wang, Hua-Ying
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [35] Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
    Jing, Chu-Yu
    Li, Sheng-Nan
    Shan, Bo-Er
    Zhang, Wei
    Tian, Wen-Juan
    Ren, Yu-Lan
    Wang, Hua-Ying
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [36] Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins
    Witkiewicz, Agnieszka K.
    McConnell, Thomas
    Potoczek, Magdalena
    Emmons, Robert V. B.
    Kurman, Robert J.
    HUMAN PATHOLOGY, 2010, 41 (01) : 26 - 32
  • [37] The Aromatase Inhibitor Anastrozole: A Novel Treatment for Complex Atypical Endometrial Hyperplasia in Premenopausal Women Who Desire Fertility Preservation
    Rubal, Lauren
    Allen, Rene
    Stanczyk, Frank
    Patel, Sherfaraz
    Bendikson, Kristin
    Paulson, Richard
    Chung, Karine
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 258A - 258A
  • [38] Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
    Mitsuhashi, Akira
    Habu, Yuji
    Kobayashi, Tatsuya
    Kawarai, Yoshimasa
    Ishikawa, Hiroshi
    Usui, Hirokazu
    Shozu, Makio
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
  • [39] Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients
    Zhou Rong
    Yang Yuan
    Lu Qun
    Wang Jianliu
    Miao Yali
    Wang Shijun
    Wang Zhiqi
    Zhao Chao
    Wei Lihui
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 424 - 428
  • [40] Predictive factors of concurrent endometrial carcinoma and the role of frozen section in patients with preoperative diagnosis of atypical endometrial hyperplasia
    Chang, Yin-Juan
    Fan, Yong-Shen
    Kariyapperuma, Reshmi Hareendra
    Xu, Yong-An
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (03) : 16 - 20